Hematology-American Society of Hematology Education Program

Papers
(The H4-Index of Hematology-American Society of Hematology Education Program is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Inherited thrombophilia and recurrent miscarriage: is there a role for anticoagulation during pregnancy?77
Your chemo is no good here: management of high-risk MCL76
When should gene therapy be considered for transfusion-dependent β-thalassemia patients?68
Bispecific antibody therapies50
Labor and delivery: DIC, HELLP, preeclampsia47
Anticoagulation at the end of life: whether, when, and how to treat40
Inpatient recognition and management of HLH39
Neurological manifestations of MGUS38
Hematopoietic cell transplantation for sickle cell disease: updates and future directions36
On the horizon: upcoming new agents for the management of ITP35
Mastocytosis demystified35
Diagnosis and therapeutic decision-making for the neutropenic patient33
Recognizing, defining, and managing CAR-T hematologic toxicities32
Has PD-1 blockade changed the standard of care for cHL?31
Individualized patient care in nodular lymphocyte-predominant Hodgkin lymphoma31
Divergent paths: management of early relapsed follicular lymphoma26
Double-refractory Hodgkin lymphoma: tackling relapse after brentuximab vedotin and checkpoint inhibitors26
To consolidate or not to consolidate: the role of autologous stem cell transplantation in MCL26
T-cell–based therapies for treating relapsed or refractory mantle cell lymphoma26
Logistics, risks, and benefits of automated red blood cell exchange for patients with sickle cell disease26
Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient26
Troubleshooting heparin resistance25
Selecting initial therapy in CLL25
Minimal intensity conditioning strategies for bone marrow failure: is it time for “preventative” transplants?24
Incidence, mechanism, and consequences of IV iron–induced hypophosphatemia24
0.14751696586609